ACLARION, INC. Proceeds from Issuance of Warrants
ACLARION, INC. (ACON) reported Proceeds from Issuance of Warrants of $9.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-06
- ACLARION, INC. proceeds from issuance of warrants for the quarter ending 2026-06-30 was $0.00.
- ACLARION, INC. proceeds from issuance of warrants for the quarter ending 2026-03-31 was $9.32M.
- ACLARION, INC. proceeds from issuance of warrants for the quarter ending 2025-06-30 was $0.00.
- ACLARION, INC. proceeds from issuance of warrants for the quarter ending 2025-03-31 was $0.00.
- ACLARION, INC. proceeds from issuance of warrants for fiscal 2025 was $1.97M.
- ACLARION, INC. proceeds from issuance of warrants for fiscal 2024 was $0.00.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $9.32M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $9.32M 10-Q · filed 2026-05-13 | ||
| 2025-12-31 | $1.97M 10-K · filed 2026-03-18 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-13 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-06-06 | ||
| 2021-06-30 | $23.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $30.39K 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $7.16K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |